Matches in SemOpenAlex for { <https://semopenalex.org/work/W4283822817> ?p ?o ?g. }
- W4283822817 endingPage "2120" @default.
- W4283822817 startingPage "2108" @default.
- W4283822817 abstract "Advanced systemic mastocytosis (AdvSM) is a rare myeloid neoplasm associated with poor overall survival (OS). This study (NCT04695431) compared clinical outcomes between patients with AdvSM treated with avapritinib in the Phase 1 EXPLORER (NCT0256198) and Phase 2 PATHFINDER (NCT03580655) trials (N = 176) and patients treated with best available therapy (BAT; N = 141). A multi-center, observational, retrospective chart review study was conducted at six study sites (four European, two American) to collect data from patients with AdvSM who received BAT; these data were pooled with data from EXPLORER and PATHFINDER. Comparisons between outcomes of OS, duration of treatment (DOT), and maximum reduction in serum tryptase were conducted between the treatment cohorts, with adjustment for key covariates. The results indicated that the avapritinib cohort had significantly better survival (adjusted hazard ratio (HR) (95% confidence interval (CI)): 0.48 (0.29, 0.79); p = 0.004) and significantly longer DOT (HR: 0.36 (0.26, 0.51); p < 0.001) compared to the BAT cohort. Additionally, the mean difference in percentage maximum reduction in serum tryptase levels was 60.3% greater in the avapritinib cohort (95% CI: -72.8, -47.9; p < 0.001). With no randomized controlled trials comparing avapritinib to BAT, these data offer crucial insights into the improved efficacy of avapritinib for the treatment of AdvSM." @default.
- W4283822817 created "2022-07-06" @default.
- W4283822817 creator A5002562635 @default.
- W4283822817 creator A5006306448 @default.
- W4283822817 creator A5016816776 @default.
- W4283822817 creator A5021124944 @default.
- W4283822817 creator A5021183522 @default.
- W4283822817 creator A5028061272 @default.
- W4283822817 creator A5035879639 @default.
- W4283822817 creator A5040851961 @default.
- W4283822817 creator A5051795460 @default.
- W4283822817 creator A5052257006 @default.
- W4283822817 creator A5057473205 @default.
- W4283822817 creator A5060849622 @default.
- W4283822817 creator A5062686747 @default.
- W4283822817 creator A5063896009 @default.
- W4283822817 creator A5065621786 @default.
- W4283822817 creator A5070033945 @default.
- W4283822817 creator A5072949561 @default.
- W4283822817 creator A5075799835 @default.
- W4283822817 creator A5078832082 @default.
- W4283822817 creator A5079623051 @default.
- W4283822817 creator A5082924494 @default.
- W4283822817 date "2022-07-05" @default.
- W4283822817 modified "2023-10-18" @default.
- W4283822817 title "Efficacy of avapritinib versus best available therapy in the treatment of advanced systemic mastocytosis" @default.
- W4283822817 cites W1494664247 @default.
- W4283822817 cites W1593000383 @default.
- W4283822817 cites W1963840931 @default.
- W4283822817 cites W1985989614 @default.
- W4283822817 cites W1987946408 @default.
- W4283822817 cites W1998752750 @default.
- W4283822817 cites W2012245921 @default.
- W4283822817 cites W2023784583 @default.
- W4283822817 cites W2076668534 @default.
- W4283822817 cites W2107058988 @default.
- W4283822817 cites W2110818436 @default.
- W4283822817 cites W2113692004 @default.
- W4283822817 cites W2121216306 @default.
- W4283822817 cites W2139464974 @default.
- W4283822817 cites W2144387798 @default.
- W4283822817 cites W2471060246 @default.
- W4283822817 cites W2472403803 @default.
- W4283822817 cites W2473366697 @default.
- W4283822817 cites W2485655499 @default.
- W4283822817 cites W2565342730 @default.
- W4283822817 cites W2592769270 @default.
- W4283822817 cites W2606840432 @default.
- W4283822817 cites W2736420338 @default.
- W4283822817 cites W2973165746 @default.
- W4283822817 cites W2982563310 @default.
- W4283822817 cites W3008002744 @default.
- W4283822817 cites W3092154892 @default.
- W4283822817 cites W3128380102 @default.
- W4283822817 cites W3206166311 @default.
- W4283822817 cites W3208311946 @default.
- W4283822817 cites W4200317891 @default.
- W4283822817 cites W4200407033 @default.
- W4283822817 cites W4210551100 @default.
- W4283822817 cites W4213193135 @default.
- W4283822817 cites W4221113170 @default.
- W4283822817 cites W95266807 @default.
- W4283822817 doi "https://doi.org/10.1038/s41375-022-01615-z" @default.
- W4283822817 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35790816" @default.
- W4283822817 hasPublicationYear "2022" @default.
- W4283822817 type Work @default.
- W4283822817 citedByCount "17" @default.
- W4283822817 countsByYear W42838228172022 @default.
- W4283822817 countsByYear W42838228172023 @default.
- W4283822817 crossrefType "journal-article" @default.
- W4283822817 hasAuthorship W4283822817A5002562635 @default.
- W4283822817 hasAuthorship W4283822817A5006306448 @default.
- W4283822817 hasAuthorship W4283822817A5016816776 @default.
- W4283822817 hasAuthorship W4283822817A5021124944 @default.
- W4283822817 hasAuthorship W4283822817A5021183522 @default.
- W4283822817 hasAuthorship W4283822817A5028061272 @default.
- W4283822817 hasAuthorship W4283822817A5035879639 @default.
- W4283822817 hasAuthorship W4283822817A5040851961 @default.
- W4283822817 hasAuthorship W4283822817A5051795460 @default.
- W4283822817 hasAuthorship W4283822817A5052257006 @default.
- W4283822817 hasAuthorship W4283822817A5057473205 @default.
- W4283822817 hasAuthorship W4283822817A5060849622 @default.
- W4283822817 hasAuthorship W4283822817A5062686747 @default.
- W4283822817 hasAuthorship W4283822817A5063896009 @default.
- W4283822817 hasAuthorship W4283822817A5065621786 @default.
- W4283822817 hasAuthorship W4283822817A5070033945 @default.
- W4283822817 hasAuthorship W4283822817A5072949561 @default.
- W4283822817 hasAuthorship W4283822817A5075799835 @default.
- W4283822817 hasAuthorship W4283822817A5078832082 @default.
- W4283822817 hasAuthorship W4283822817A5079623051 @default.
- W4283822817 hasAuthorship W4283822817A5082924494 @default.
- W4283822817 hasBestOaLocation W42838228171 @default.
- W4283822817 hasConcept C126322002 @default.
- W4283822817 hasConcept C167135981 @default.
- W4283822817 hasConcept C168563851 @default.
- W4283822817 hasConcept C203014093 @default.
- W4283822817 hasConcept C207103383 @default.
- W4283822817 hasConcept C2779134260 @default.